Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Bohula EA, Phil D, Wiviott SD, et al.
N Engl J Med. 2018;379(12):1107-17.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Bohula EA, Phil D, Wiviott SD, et al.
N Engl J Med. 2018;379(12):1107-17.
Leggi
Verma S, McMurray JJV
Diabetologia 2018;61(10):2108-17
Leggi
Lupsa BC, Inzucchi SE
Diabetologia 2018;61(10):2118-25
Leggi
Sattar N, Fitchett D, Hantel S, et al.
Diabetologia 2018;61(10):2155-63
Leggi
Ohkuma T, Peters SEA, Woodward M
Diabetologia 2018;61(10):2140-54
Leggi
van der Velde JHPM, Schaper NC, Stehouwer CDA, et al.
Diabetologia. Pub. online 10 September 2018
Leggi
Persson M, Shah PS, Rusconi F, et al.
JAMA Pediatr. 2018;172(9):867-75
Leggi
Garg SK, Peters AL, Buse JB, Danne T
Diabetes Technology & Therapeutics. Pub. online 1 Sep 2018
Leggi
Gopalan A, Mishra P, Alexeeff SE, et al.
Diabetic Medicine. Pub. online 03 September 2018
Leggi
Park C, Le QA
Diabetes Technology & Therapeutics. Pub. online 1 Sep 2018
Leggi